Unjha Formulations Ltd share price logo

Unjha Formulations Share Price

BSE: 531762

Small Cap

Healthcare Sector

₹22.95

-0.11

(-0.48%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Unjha Formulations Stock Performance

as on February 6, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹22.75
    ₹23.48
    downward going graph

    0.87%

    Downside

    2.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹19.99
    ₹30.40
    downward going graph

    12.90%

    Downside

    32.46%

    Upside

    downward going graph

Unjha Formulations share price movements today

Previous Close
₹23.06
Open
₹23.01
Volume
1,194.00
Upper Circuit
₹27.67
Lower Circuit
₹18.45
Day's Low - High
₹22.75 - ₹23.48
52 Week Low - High
₹19.99 - ₹30.40

Unjha Formulations Historical Returns

1 Month Return
-8.16 %
3 Month Return
-2.75 %
1 Year Return
-12.54 %
3 Year Return
+ 35.4 %
5 Year Return
+ 154.15 %

Unjha Formulations Fundamentals

as on February 6, 2026 at 4:01 pm IST

Market Cap

₹10.28 Cr

Return on Equity (ROE)

8.77

PE Ratio (TTM)

0

Return on capital employed (ROCE)

11.55

Beta (LTM)

0.6

P/B Ratio

3.11

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

9.09

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Unjha Formulations Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unjha Formulations with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Unjha Formulations Ltd image
Unjha Formulations Ltd
NA10.2830.83%0.00NA13
Blue Jet Healthcare Ltd image
Blue Jet Healthcare Ltd
BUY7,137.23-0.09%0.00135498
Infinium Pharmachem Ltd image
Infinium Pharmachem Ltd
NA342.8339.54%0.697155
Fabino Enterprises Ltd image
Fabino Enterprises Ltd
NA2.89-13.17%0.65NA18
Vivo Bio Tech Ltd image
Vivo Bio Tech Ltd
NA63.18-9.84%0.71746
See all

Unjha Formulations Share Price Target

Get share price movements and forecasts by analysts on Unjha Formulations.

Source: S&P Global Market Intelligence

Unjha Formulations Stock’s Investor Sentiment and Interest

Search interest for Unjha Formulations Ltd Stock has increased by 65% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:65% versus previous 30 day period

Unjha Formulations Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
2.84
3.76
4.76
5.55
4.43
3.95
3.78
3.76
2.37
3.61
4.29
4.41
Other Income
0.01
-0.01
0.01
-
0.01
-
0.02
0.01
0.07
0.02
0.06
0.03
Total Income
2.84
3.75
4.77
5.54
4.44
3.95
3.81
3.77
2.44
3.63
4.35
4.44
Expenses
2.95
3.55
4.87
5.13
4.37
3.23
3.89
3.52
2.7
3.21
3.5
4.16
Operating Profit
-0.11
0.21
-0.11
0.42
0.06
0.72
-0.11
0.24
-0.33
0.4
0.79
0.25
Operating Profit Margin %
-3.87%
5.59%
-2.31%
7.57%
1.35%
18.23%
-2.91%
6.38%
-13.92%
11.08%
18.41%
5.67%
Profit Before Interest, Tax and Depreciation
-0.11
0.2
-0.1
0.41
0.07
0.72
-0.09
0.25
-0.26
0.42
0.85
0.28
Interest
0.02
0.02
-
-
0.05
-
-
-
-
-
-
-
Depreciation
0.05
-
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.03
0.04
Profit Before Tax
-0.18
0.18
-0.12
0.39
0
0.7
-0.11
0.23
-0.29
0.39
0.82
0.24
Tax Paid
0.05
-
-
-
0.18
-
-
-
0.12
-
-
-
Profit After Tax
-0.22
0.18
-0.12
0.39
-0.18
0.7
-0.11
0.22
-0.41
0.39
0.82
0.24
Total Net profit including share of profit / Loss from associate company
-0.22
0.18
-0.12
0.39
-0.18
0.7
-0.11
0.22
-0.41
0.39
0.82
0.24
EPS
-0.5
0.4
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53
Actual EPS
-0.5
0.4
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53
Adjusted EPS
-0.5
0.4
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53
Diluted EPS
-0.5
0.4
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53

Unjha Formulations Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
12.24
11.3
11.42
10.6
9.96
14.16
13.15
18.5
13.86
Other Income
-
-
-
0.26
0.22
0.19
0.03
0.01
0.11
Total Income
12.24
11.33
11.52
10.86
10.17
14.35
13.18
18.51
13.98
Expenses
11.86
10.95
11.12
10.35
9.81
13.84
12.72
17.92
13.35
Operating Profit
0.38
0.35
0.3
0.25
0.15
0.32
0.43
0.58
0.51
Operating Profit Margin %
3.1%
3.1%
2.63%
2.36%
1.51%
2.26%
3.27%
3.14%
3.68%
Profit Before Interest, Tax and Depreciation
0.38
0.38
0.41
0.5
0.36
0.51
0.46
0.59
0.63
Interest
0.1
0.02
0.02
0.12
0.17
0.13
0.06
0.06
0.01
Depreciation
0.09
0.1
0.09
0.08
0.08
0.08
0.08
0.08
0.1
Profit Before Tax
0.19
0.26
0.3
0.3
0.11
0.3
0.32
0.45
0.52
Tax Paid
-
-
-
-
-
0.05
0.05
0.18
0.12
Profit After Tax
0.19
0.26
0.3
0.31
0.1
0.25
0.28
0.28
0.41
Total Net profit including share of profit / Loss from associate company
0.19
0.26
0.3
0.31
0.1
0.25
0.28
0.28
0.41
EPS
0.66
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
Actual EPS
0.66
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
Adjusted EPS
0.66
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
Diluted EPS
0.66
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91

Unjha Formulations Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.41
0.39
0.14
-0.12
0.39
-0.7
0.28
-0.26
1.03
-0.04
Cash Flow from Investing Activities
-0.02
-0.28
0.06
0.04
-0.1
-0.06
-0.02
-0.1
-0.11
-0.18
Cash Flow from Financing Activities
-0.4
0.05
-0.05
0.23
-
-
-
-0.06
-0.05
-0.01
Net Cash Flow
-0.01
0.15
0.15
0.16
0.29
-0.77
0.25
-0.42
0.86
-0.23

Unjha Formulations Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
DII
0.11%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Public
62.96%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
Total Outstanding Shares
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
Total Shareholders
3,993
3,963
3,993
4,012
3,933
3,985
3,969
4,208
4,273
4,213
4,284
4,251

Unjha Formulations Corporate Actions

View detailed summary of the earnings and dividend history of Unjha Formulations.

  • Unjha Formulations Ltd Earnings Results

    Unjha Formulations Ltd’s net profit jumped 9.09% since last year same period to ₹0.24Cr in the Q3 2025-2026. On a quarterly growth basis, Unjha Formulations Ltd has generated -70.73% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Unjha Formulations Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 22.0% return, outperforming this stock by 34.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 158.9% return, outperforming this stock by 122.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 36.93% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 63.08% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, Unjha Formul. stock has moved down by -2.3%

About Unjha Formulations Ltd

Established in June 1987, Unjha Formulations is a manufacturer of pharmaceuticals based in the Mehsana district of Gujarat. It produces a range of human and veterinary products, recently launching 4 new products in 199798, such as Bericof Protobal, NT Formentin Tablets, Nalizole and Isabgol Husk based products. The company has experienced major success in expanding its customer base in India and has even made attempts to export their products to other countries, achieving an export turnover of Rs.0.98 during 199798, with a confirmed export order of Rs.30.00 lacs. Unjha Formulations is one of the largest suppliers of Isabgol in India.

Revenue: ₹4.41Cr as on December 2025 (Q3 FY26)
Net Profit: ₹0.24Cr as on December 2025 (Q3 FY26)
Chairperson Name: Jashodaben S Patel
OrganisationUnjha Formulations Ltd
HeadquartersPatan
IndustryPharmaceuticals
CEOJashodaben S Patel
E-voting on sharesClick here to vote

FAQs

What is Unjha Formulations share price today?

Unjha Formulations share price today stands at ₹22.95 as on at the close of the market. Unjha Formulations share today touched a day high of ₹23.48 and a low of ₹22.75.

What is the 52 week high and 52 week low range for Unjha Formulations share?

Unjha Formulations touched a 52 week high of ₹30.4 and a 52 week low of ₹19.99. Unjha Formulations share price today i.e. is closed at ₹22.95, which is -24.51% down from its 52 week high and 14.81% up from its 52 week low.

What is Unjha Formulations's market capitalisation today?

Unjha Formulations market capitalisation is ₹10.28 Cr as on .

How to buy Unjha Formulations shares?

To buy Unjha Formulations shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 531762 or Unjha Formulations Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Unjha Formulations shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Unjha Formulations trading volume today?

Unjha Formulations trading volume is 1,194.00 as on . This means that 1,194.00 shares of Unjha Formulations were bought and sold on the stock market during today's trading session.